Get to the root of your digestive issues with gut-brain therapy techniques that help you self-manage your gut symptoms in just 6-weeks.
IBS, functional dyspepsia, functional constipation, and functional heartburn are now classified as gut-brain disorders - conditions driven by miscommunication between the gut and brain. The same gut-brain dysfunction also explains why many people with IBD continue to experience pain, constipation, or diarrhea even when their disease is in remission.
When the gut and brain fail to communicate properly, the body can misinterpret normal digestive processes as pain or discomfort. This heightened sensitivity, known as visceral hypersensitivity, can make the gut more reactive and contribute to gastrointestinal symptoms.
Nerva combines evidence-based gut-brain therapy techniques with real human support to help you self-manage symptoms, rebuild confidence, and get back to living fully.
The Nerva program was co-founded by Dr. Simone Peters, who ran a clinical trial with Monash University that found gut-brain therapy therapy worked just as well as the Low FODMAP diet in helping you participants well with and self-manage IBS.
Gut-brain therapy techniques targets the source of the problem: oversensitive nerves in the gut.
Gut-brain therapy techniques teaches you how to address this miscommunication between the gut and brain.
Gut-brain therapy techniques has been shown to help with constipation, diarrhea and mixed IBS.
Studies have shown gut-brain therapy techniques can help you achieve long-lasting IBS management.
Answer questions about you and your gut history to see if Nerva can work for you.
Daily gut-brain sessions, educational content, and goal oriented progress, tailored to your preferences.
Learn skills that can help you teach your brain to ignore false alarms from the gut triggered by food and stress.
Live the life you want, free from the control of digestive diseases.
.png)
Backed by 5+ studies including a randomized controlled trial.
9/10 members see meaningful progress in 4-6 weeks.
Learn skills focused on retraining the gut-brain axis.
Short daily sessions from the comfort of your home.
The modern entertainment market thrives on blending cultural backgrounds. For example, prominent actresses like Olga Kurylenko on Wikipedia began their journeys at a young age moving from Eastern Europe to global screens. Similarly, digital media projects focusing on a "Kiz Olya" (Girl Olya) motif often bridge the gap between traditional storytelling and modern influencer dynamics, making it relatable to multicultural audiences. 2. The Power of "Dizi" Culture and Streaming Integration
: Her entertainment content centers on fashion, family, motherhood, and travel, as seen on her olya_migunova_ Instagram. Olya Abramovich (Media Personality) Kiz Olya 12 Yasinda Oyuncu Secimi Porno txt
(often referred to as "Yanık Sesli Kız" or the "Girl with the Burning Voice") has emerged as a prominent figure in the Turkish entertainment and digital media landscape, particularly on platforms like TikTok and Instagram. Her content blends traditional cultural elements with modern viral storytelling, making her a unique "oyuncu" (performer/actress) in the creator economy. 🎭 Entertainment & Media Profile The modern entertainment market thrives on blending cultural
Kiz Olya Yasinda Oyuncu is a talented and versatile actress who has made a significant impact on the Turkish entertainment and media industry. Her dedication to her craft, her passion for storytelling, and her on-screen presence have earned her a loyal fan base and critical acclaim. As she continues to grow and evolve as an artist, we can expect to see even more impressive performances from her in the future. Her content blends traditional cultural elements with modern
Historically, young talent in Turkish cinema and television remained confined to specific narrative roles (e.g., the daughter or younger sibling). Today, multi-platform media networks leverage young actors across social media, YouTube, and traditional television simultaneously. Audiences routinely track the age ("yaşında") and evolution of these stars, turning minor roles into massive digital footprints. 2. Cross-Cultural Casting Realities
: Interactive videos where she invites users to join "Türkü Ziyafeti" (Folk Song Feasts), fostering a sense of community among viewers who value Turkish cultural identity. 3. Media Distribution and Reach
"Hi, it's Alex, one of the founders of Nerva alongside Chris and Dr. Simone Peters.
We designed Nerva to help people with gut-brain disorders get back to a happy, normal life, free of flare-up worries. We're so proud of the fact that we've already helped over 300,000 people live better. Yet, we understand Nerva may not work for some people which is why we have a 100% money back guarantee.
If you finish your 6-week program and think Nerva hasn't helped you manage your symptoms, simply email support for a full refund of the Nerva program."
- Alex Naoumidis, Co-Founder and Co-CEO, Mindset Health
Based on studies that helped 3 in 4 people manage their gut symptoms.
15 minutes a day for 6 weeks. Short and relaxing sessions that fit with your schedule.
Discover helpful and calming flare-up exercises, like our deep breathing techniques.
Listen anytime and anywhere (home, office, couch, you name it).
Learn about gut-brain disorders with a range of easy to understand in-app articles.
Say bye to bots. We have real Nerva team members ready to help!
.svg)
.svg)
1) Anderson, Ellen J. BNutSci, MDiet1,2; Peters, Simone L. BSc (Psychophysiology) (Hons), PhD1; Gibson, Peter R. MBBS(Hons), MD1,2; Halmos, Emma P. BNutDiet, PGradDipBSc, PhD1,2. Comparison of Digitally Delivered Gut-Directed Hypnotherapy Program With an Active Control for Irritable Bowel Syndrome. The American Journal of Gastroenterology 120(2):p 440-448, February 2025. | DOI: 10.14309/ajg.0000000000002921 2) Peters, S. L., Yao, C. K., Philpott, H., Yelland, G. W., Muir, J. G., & Gibson, P. R. (2016). Randomised clinical trial: the efficacy of gut-directed hypnotherapy is similar to that of the low FODMAP diet for the treatment of irritable bowel syndrome. Alimentary pharmacology & therapeutics, 44(5), 447–459. https://doi.org/10.1111/apt.13706
